I

n recent years, Robert Ripley has watched spiking drug prices menace his budget like a fast-rising flood.

The longtime chief of pharmacy for Trinity Health, a Catholic chain of 93 hospitals from New York to California, said he’s never seen anything like it in his 30-plus years in the business. The eye-popping prices of new branded drugs are one issue. But even worse are the wild price hikes and sudden shortages of generics that have been available for many decades.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Yeah, I already subscribe to the Globe, and this is an article in today’s paper. Why should I have to pay again to access it?

  • Congress should pass a law requiring any drug producer that received federal money for research to charge no more in the U S than the lowest price they charge outside the U S.

  • My insurance company is making me discontinue a drug, Gabapentin, Horizant to Gabapentin, Gralise due to price. The new drug didn’t work as well as the old one also.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.